Larvol Delta - Akari-Therapeutics-Reports-Breakthrough-Preclinical-Data-Demonstrating-Synergistic-Activity-of-AKTX101-with-KRAS-Inhibition-in-KRASMutated-Pancreatic-Cancer-Models

AKTX-101 - Akari Therap

https://www.globenewswire.com/news-release/2026/05/21/3299790/0/en/Akari-Therapeutics-Reports-Breakthrough-Preclinical-Data-Demonstrating-Synergistic-Activity-of-AKTX-101-with-KRAS-Inhibition-in-KRAS-Mutated-Pancreatic-Cancer-Models.html

May 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next